Marinus Pharmaceuticals Inc (NASDAQ: MRNS) Is Getting Increasingly Hard To Ignore
Currently, there are 54.58M common shares owned by the public and among those 50.81M shares have been available to trade. The company’s stock has a 5-day price change of -84.15% and -86.73% over the past three months. MRNS shares are trading -88.04% year to date (YTD), with the 12-month market performance down to -82.13% lower. […]
Stick With Marinus Pharmaceuticals Inc (MRNS). The Bull Are Alive And Well
Suvretta Capital Management LLC recently announced the acquisition of new stake in Marinus Pharmaceuticals Inc (NASDAQ:MRNS). The institutional investor has increased its shareholding in the Healthcare company by 28.28% to 5.2 million shares with purchase of 1.15 million shares. This fresh investment now brings its stake to 9.54% valued currently at $35.03 million. In addition, […]
